Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App




Samsung Introduces New High-End Ultrasound System 'V8' with Artificial Intelligence (AI) Functions

By HospiMedica International staff writers
Posted on 15 Oct 2021

NeuroLogica Corp. More...

, (Danvers, MA, USA), the US healthcare subsidiary of Samsung Electronics Co., Ltd. (Suwon-si, South Korea), has launched the V8, a high-end ultrasound system that provides enhanced image quality, usability and convenience for ultrasound professionals.

The V8 was recently cleared by the US Food and Drug Administration for commercial use in the US. The feature-packed device includes two new artificial intelligence (AI) functions. The first is "NerveTrack", an exciting AI technology that detects the location of nerves during live scanning. The second is “UterineAssist”, which detects tissue changes and assists the user with measurements of the uterus.

Samsung’s Crystal Architecture is the core of the V8’s exceptional image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images. The V8 is equipped with many premium technologies such as ShadowHDR, designed to suppress shadows and enhance the clarity of displayed grayscale images; S-Shearwave Imaging, which provides information about tissue stiffness as a result of disease using ultrasonic transverse elasticity; S-Fusion technology, which allows synchronous alignment of medical images of ultrasound with one or more cross-sectional studies such as MRI, which are instantly reconstructed in the corresponding plane; and MV-Flow, which enhances the visualization of low-flow blood flow states.

The V8 also has various 3D, 4D and 5D technologies that allow the user to view anatomy with exceptional detail. One tool, 5D CNS+, simplifies fetal brain assessment by automatically providing nine planes simultaneously with biometric measurements. The V8 will deliver a new level of versatility and value to a wide range of diagnostic medical ultrasound departments.

“We are pleased to launch the V8. We designed it with the user in mind, from its premium imaging engine to its ergonomic design,” said David Legg, Vice President, Ultrasound and Digital Radiography, NeuroLogica. “The “V” in “V8” stands for “versatile” because a wide range of departments from obstetrics to radiology and orthopedics to cardiology can make use of its complex functions. We anticipate the V8 to become a flagship product within the high-end ultrasound category.”

Related Links:
NeuroLogica Corp. 
Samsung Electronics Co., Ltd. 

 


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.